Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al.

Journal of the Neurological Sciences 2026

View at publisher

Authors: Aman Ullah, Muhammad Mustafa Khan, Abdullah Abdullah, Asiya Shahzad

DOI: 10.1016/j.jns.2026.125803

Cited by: 1

References: 3

Fields of Study & Subjects

Diabetes Treatment and Management Neuroendocrine Tumor Research Advances Receptor Mechanisms and Signaling

References 3